有机化学 ›› 2018, Vol. 38 ›› Issue (11): 3086-3093.DOI: 10.6023/cjoc201805020 上一篇    下一篇

研究论文

N-苯基吡唑脲类FAK II型抑制剂的结构优化与构效关系研究

龚超超, 谈寒一, 张倩   

  1. 复旦大学药学院药物化学教研室 上海 201203
  • 收稿日期:2018-05-08 修回日期:2018-06-07 发布日期:2018-06-29
  • 通讯作者: 张倩 E-mail:zhangqian511@shmu.edu.cn
  • 基金资助:

    上海市科委生物医药支撑(No.14431900600)及复旦大学药学院融合基金(No.RO-MY201708)资助项目.

Structure Optimization and Structure-Activity Relationship Study of a Kind of Type II FAK Inhibitors with N-Phenylpyrazole Ureas

Gong Chaochao, Tan Hanyi, Zhang Qian   

  1. Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203
  • Received:2018-05-08 Revised:2018-06-07 Published:2018-06-29
  • Supported by:

    Project supported by the Shanghai Science and Technology Commission Support Project for Biological Medicine (No. 14431900600) and the School of Pharmacy of Fudan University Fusion Fund (No. RO-MY201708).

以Ⅱ型黏着斑激酶(FAK)抑制剂化合物2为先导化合物,结合FAK变构疏水腔的结构特征,对其尾部结构N-苯基吡唑进行了结构改造和优化,共获得9个目标化合物,其中4个化合物保持了与先导化合物同水平的酶抑制活性,N1-(4-(6-氨基-9H-嘌呤-9-基)苯基)-N3-(1-(4-乙酰氨基苯基)-3-叔丁基-1H-吡唑-5-基)脲(9e)表现出优于先导化合物2倍的FAK抑制活性,IC50值为41 nmol/L.表明N-苯基吡唑结构中苯环对位有更多结构优化空间,可通过与周边残基形成氢键从而提高化合物活性.

关键词: 黏着斑激酶, 变构疏水口袋, II型抑制剂, N-苯基吡唑, 结构优化

The structure modification and optimization focused on the N-phenylpyrazole motif of the lead compound 2 were conducted on basis of the structural features of focal adhesion kinase (FAK) allosteric hydrophobic pockets. Nine aimed compounds were designed and synthesized, among which four compounds maintained the inhibitory activity against FAK at the same level as 2. Especially, N-(4-(5-(3-(4-(6-amino-9H-purin-9-yl) phenyl) ureido)-3-(tert-butyl)-1H-pyrazol-1-yl) phenyl) ace-tamide (9e) demonstrated 2-fold higher inhibition potency than that of the lead compound with the IC50 value of 41 nmol/L. It is suggested that the bioactivity could be further improved by introducing more proper groups at the 4-position of phenyl to increase the interactions between the substituents and the residues around them.

Key words: focal adhesion kinase, allosteric hydrophobic pocket, type II inhibitor, N-phenylpyrazole, structure optimization